CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5 | +25.0% | 341 | 0.0% | 0.00% | – |
Q2 2023 | $4 | +33.3% | 341 | 0.0% | 0.00% | – |
Q1 2023 | $3 | +50.0% | 341 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.8% | 341 | +124.3% | 0.00% | – |
Q3 2022 | $1,000 | – | 152 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 152 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 152 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -66.7% | 152 | -59.8% | 0.00% | – |
Q3 2020 | $3,000 | +200.0% | 378 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 378 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 378 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | -50.0% | 378 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 378 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | -40.0% | 378 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | -16.7% | 378 | -46.0% | 0.00% | – |
Q4 2018 | $6,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |